Physician

Michelle L Rein, MD

According to 2025 Medicare claims, Michelle Rein, MD (NPI: 1477541423) practices family practice in the La Crosse-Onalaska, WI-MN market, with the plurality of this provider's patient population coming from Houston, MN. This provider's primary affiliated billing organization is MAYO CLINIC HEALTH SYSTEM-SOUTHWEST WISCONSIN REGION, INC. (NPI: 1629056049; TIN: 390806374) and primary practice location at 55921-1066. Rein is affiliated with the Mayo Clinic Community ACO, LLC (ACO ID: A4617) and Caravan Health ACO 50 LLC (ACO ID: A5160), participating under the MSSP model.

Rein's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 231 traditional Medicare patients, billed 770 HCPCS/CPT codes, and received $50,132 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 6,773 prescription claims across 444 beneficiaries totaling $443,649 in drug costs, led by Jardiance (Empagliflozin). DME data shows 83 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $31,924 to $50,132. Concurrently, Part D prescription costs have changed little. For DME billing, reported payments moved up and down with repeated peaks and valleys, starting at $14,488 and ending at $22,883.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	204	605	$31,924
2016	191	589	$30,407
2017	198	490	$22,840
2018	143	352	$17,151
2019	242	758	$43,417
2020	229	568	$29,053
2021	234	696	$49,506
2022	226	574	$41,595
2023	268	606	$41,110
2024	231	770	$50,132

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	357	6,382	$398,274
2016	374	6,563	$384,063
2017	373	6,917	$356,477
2018	328	6,229	$351,161
2019	345	6,169	$353,310
2020	350	6,560	$338,187
2021	360	6,070	$363,714
2022	344	6,061	$370,562
2023	391	6,540	$450,303
2024	444	6,773	$443,649

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	14	84	$5,435
2016	12	89	$4,020
2017	N/R	117	$2,210
2018	12	35	$469
2019	15	91	$2,620
2020	12	209	$8,368
2021	11	172	$7,942
2022	12	215	$9,932
2023	N/R	158	$10,532
2024	N/R	83	$2,790

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	147	147	$134
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	164	287	$66
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	101	131	$45
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	110	156	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	83	3,852	$76,745
Eliquis	Apixaban	71	3,234	$63,148
Xarelto	Rivaroxaban	51	2,240	$41,245
Ozempic	Semaglutide	25	1,162	$38,530
Mounjaro	Tirzepatide	13	364	$10,921

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	20	$1,885
Q0513	Pharmacy dispensing fee for inhalation drug(s); per 30 days	N	N/R	12	$287
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	14	$260
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	N/R	24	$235
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	N	N/R	13	$123

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Michelle L. Rein, MD?

Tedicare shows public-source Medicare data for Michelle L. Rein, MD (NPI 1477541423), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michelle L. Rein, MD have ACO affiliation data?

Michelle L. Rein, MD is shown with ACO affiliation data for Mayo Clinic Community ACO, LLC (MSSP, ACO ID A4617) and Caravan Health ACO 50 LLC (MSSP, ACO ID A5160).

What billing organization is linked to Michelle L. Rein, MD?

Michelle L. Rein, MD is linked to MAYO CLINIC HEALTH SYSTEM-SOUTHWEST WISCONSIN REGION, INC. (billing NPI 1629056049) in the available physician profile data.

Does Michelle L. Rein, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.